Breaking News Instant updates and real-time market news.

MYOK

MyoKardia

$58.92

-0.33 (-0.56%)

16:48
11/04/19
11/04
16:48
11/04/19
16:48

MyoKardia reports Q3 EPS ($3.07), may not compare to consensus ($1.91)

Q3 EPS was ($3.07), of which ($1.73) was related to the non-recurring repurchase from Sanofi of royalty rights to mavacamten and MYK-224, and ($1.34) was related to loss from operations. MyoKardia did not record revenue from the Sanofi collaboration during Q3. MyoKardia fulfilled its research and development obligations under the collaboration agreement during the year ended December 31, 2018, and no further revenue will be recorded under the agreement. Cash, cash equivalents and investments as of September 30, 2019 were $480.4M, compared to $394.8M as of December 31, 2018.

  • 11

    Nov

MYOK MyoKardia
$58.92

-0.33 (-0.56%)

09/19/19
GUGG
09/19/19
INITIATION
Target $84
GUGG
Buy
MyoKardia initiated with a Buy at Guggenheim
Guggenheim analyst Etzer Darout started MyoKardia with a Buy rating and $84 price target.Target $84.
09/19/19
GUGG
09/19/19
INITIATION
Target $84
GUGG
Buy
Guggenheim starts 'diamond in the rough' MyoKardia at Buy
Guggenheim analyst Etzer Darout started MyoKardia (MYOK) with a Buy rating, identifying the company and Zealand Pharma (ZEAL) as "diamonds in the rough" that are focused on therapies for cardiovascular and metabolic disorders and targeting therapeutic segments where patients are more homogenous and/or targets are validated. He currently value MYOK's mavacamten lead program in obstructive hypertrophic cardiomyopathy, or oHCM, at $63 per share with a 75% probability of success, Darout noted in his initiation. He set a $84 price target on MyoKardia shares.
09/19/19
GUGG
09/19/19
INITIATION
GUGG
Buy
Zealand Pharma initiated with a Buy at Guggenheim
Guggenheim analyst Etzer Darout started Zealand Pharma (ZEAL) with a Buy rating, identifying the company and MyoKardia (MYOK) as "diamonds in the rough" that are focused on therapies for cardiovascular and metabolic disorders and targeting therapeutic segments where patients are more homogenous and/or targets are validated. He sees Zealand's major near-term driver being gleplagutide's pivotal data in patients with short bowel syndrome, due in the second half of 2020. He has a price target of DKK 235 on the local shares of ZEAL-DK, noting that Guggenheim is terminating coverage of the ADR shares of Zealand.
09/20/19
09/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Sell at Pivotal Research. 2. Carvana (CVNA) initiated with an Outperform at Oppenheimer. 3. Zealand Pharma (ZEAL) and MyoKardia (MYOK) were initiated with a Buy at Guggenheim. 4. Wayfair (W) initiated with a Sell at Berenberg. 5. Eton Pharmaceuticals (ETON) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

11:00
12/13/19
12/13
11:00
12/13/19
11:00
General news
Today's U.S. reports »

Today's U.S. reports…

GPS

Gap

$16.66

-0.36 (-2.12%)

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

SPT

Sprout Social

$0.00

(0.00%)

10:52
12/13/19
12/13
10:52
12/13/19
10:52
Syndicate
Sprout Social indicated to open at $19.25, IPO priced at $17.00 »

Sprout Social (SPT)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

10:47
12/13/19
12/13
10:47
12/13/19
10:47
General news
U.S. Trade Representative says Phase One trade deal with China 'enforceable' »

United States Trade…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$286.83

3.03 (1.07%)

10:45
12/13/19
12/13
10:45
12/13/19
10:45
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/13/19
12/13
10:45
12/13/19
10:45
General news
Breaking General news story  »

New York Federal Reserve…

10:45
12/13/19
12/13
10:45
12/13/19
10:45
General news
Breaking General news story  »

New York Federal Reserve…

ALG

Alamo Group

$117.70

0.51 (0.44%)

10:43
12/13/19
12/13
10:43
12/13/19
10:43
Conference/Events
Alamo Group management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

ABT

Abbott

$86.48

0.5 (0.58%)

10:40
12/13/19
12/13
10:40
12/13/19
10:40
Hot Stocks
Abbott raises quarterly dividend 12.5% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPO

Exponent

$65.46

-0.62 (-0.94%)

10:37
12/13/19
12/13
10:37
12/13/19
10:37
Conference/Events
Exponent management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FLWS

1-800-Flowers.com

$13.56

0.29 (2.19%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Conference/Events
1-800-Flowers.com management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FFIV

F5 Networks

$142.79

-0.84 (-0.58%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Periodicals
Police raid Moscow office of F5 Networks' NGINX, ZDNet reports »

On Thursday, police…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$8.89

0.21 (2.42%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Options
Spectrum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$133.61

33.22 (33.09%)

10:34
12/13/19
12/13
10:34
12/13/19
10:34
On The Fly
Sarepta jumps as analysts react to 'surprise' FDA reversal on Vyondys53 »

Shares of Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.02

(0.00%)

10:32
12/13/19
12/13
10:32
12/13/19
10:32
Hot Stocks
Gap's Old Navy unit teams up with Postmates for on-demand gift delivery »

Gap's Old Navy unit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
12/13/19
12/13
10:30
12/13/19
10:30
General news
Treasury Action: yields remain lower, led by the front end, amid a lack of clarity »

Treasury Action: yields…

10:30
12/13/19
12/13
10:30
12/13/19
10:30
General news
The October U.S. business inventory report tracked estimates »

The October U.S. business…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.78

0.64 (0.20%)

10:29
12/13/19
12/13
10:29
12/13/19
10:29
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says Phase Two…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$317.78

0.64 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$318.00

0.86 (0.27%)

10:29
12/13/19
12/13
10:29
12/13/19
10:29
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says 25% tariffs on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$318.00

0.86 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$318.23

1.09 (0.34%)

10:27
12/13/19
12/13
10:27
12/13/19
10:27
General news
Trump says Dec. 15 tariffs will not be charged due to phase one deal »

President Trump just…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$318.23

1.09 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$23.91

0.91 (3.96%)

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

MSFT

Microsoft

$154.18

0.95 (0.62%)

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Hot Stocks
Microsoft unveils Xbox Series X, available Holiday 2020 »

Microsoft announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
12/13/19
12/13
10:25
12/13/19
10:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY is…

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call »

Media Analyst Quadrani…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.